Baker David Charles 4
4 · Vallon Pharmaceuticals, Inc. · Filed Mar 1, 2022
Insider Transaction Report
Form 4
Baker David Charles
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15$5.63/sh+61,000$343,430→ 61,000 totalExercise: $5.63Exp: 2032-02-15→ Common Stock (61,000 underlying)
Footnotes (2)
- [F1]Reported late due to administrative error.
- [F2]Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.